[Pilot study of antiretroviral therapy in Djibouti]
AbstractA cross-sectional survey was conducted among 112 HIV positive patients who had received antiretroviral therapy for > 3 months to assess the efficacy of treatment [viral load < 400 copies/mL]. The median age at enrolment was 36 years, 90% of patients were at the AIDS stage and median CD4 rate was 118/mm. Patients received a combined treatment of 2 NRTI +1 NNRTI [51%], 3 NRTI [45%] and 2 NRTI+1 PI [4%]. Virological efficacy was seen in 74% of the patients, irrespective of the prescribed protocol and the initial clinical and immunological profile. Mean improvements measured were 20% on the Karnofsky index [KI], 2.1 kg/m in body mass index and 82 cells/mm in CD4. The prevalence of side effects was 84%. The predictors for treatment success were quality of care and KI > 70%
Ahmed, A.A. & Latoundji, S. (2007). [Pilot study of antiretroviral therapy in Djibouti]. http://www.who.int/iris/handle/10665/117378
EMHJ - Eastern Mediterranean Health Journal, 13 (6), 1274-1285, 2007
MetadataShow full item record
Showing items related by title and MeSH subject.
World Health Organization; Keebler, Daniel; Revill, Paul; Braithwaite, Scott; Phillips, Andrew; Blaser, Nello; Borquez, Annick; Cambiano, Valentina; Ciaranello, Andrea; Estill, Janne; Gray, Richard; Hill, Andrew; Keiser, Olivia; Kessler, Jason; Menzies, Nicolas, A; Nucifora, Kimberly, A; Vizcaya, Salazar; Walker, Simon; Welte, Alex; Easterbrook, Philippa; Doherty, Meg; Hirnschall, Gottfried; Hallett, Timothy, B (WHO/HIV/2013.61, 2013)